Naoto Ishibashi

500 total citations
14 papers, 317 citations indexed

About

Naoto Ishibashi is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Hepatology. According to data from OpenAlex, Naoto Ishibashi has authored 14 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Hepatology. Recurrent topics in Naoto Ishibashi's work include Retinoids in leukemia and cellular processes (7 papers), Liver physiology and pathology (3 papers) and Blood properties and coagulation (2 papers). Naoto Ishibashi is often cited by papers focused on Retinoids in leukemia and cellular processes (7 papers), Liver physiology and pathology (3 papers) and Blood properties and coagulation (2 papers). Naoto Ishibashi collaborates with scholars based in Japan, United Kingdom and Norway. Naoto Ishibashi's co-authors include Soichi Kojima, Hisataka Moriwaki, Hideki Tatsukawa, Makiko Watanabe, Tetsuro Sano, Masataka Okuno, Hiroyuki Tsuchiya, Tomohiko Sakabe, Akihiro Kurimasa and Yoshiko Hoshikawa and has published in prestigious journals such as Gastroenterology, PLoS ONE and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Naoto Ishibashi

14 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Naoto Ishibashi Japan	11	160	56	44	42	36	14	317
Litian Ma China	9	149 0.9×	37 0.7×	18 0.4×	10 0.2×	16 0.4×	26	287
Ghazaleh Eskandari United States	10	77 0.5×	26 0.5×	55 1.3×	47 1.1×	33 0.9×	12	381
Yan-Shi Guo United States	11	160 1.0×	56 1.0×	31 0.7×	11 0.3×	48 1.3×	15	402
Sharon W. Lin United States	8	220 1.4×	20 0.4×	14 0.3×	7 0.2×	100 2.8×	11	445
M Donnadieu France	12	117 0.7×	31 0.6×	12 0.3×	15 0.4×	46 1.3×	50	402
Xiaolin Zhong China	10	96 0.6×	47 0.8×	27 0.6×	13 0.3×	73 2.0×	47	299
Joanna Kurzepa Poland	8	76 0.5×	76 1.4×	17 0.4×	30 0.7×	65 1.8×	15	276
Tania Di Raimo Italy	10	118 0.7×	55 1.0×	37 0.8×	21 0.5×	32 0.9×	15	309
Caiying Ye China	13	197 1.2×	66 1.2×	11 0.3×	6 0.1×	13 0.4×	24	349
Loren M. Brown United States	7	174 1.1×	13 0.2×	36 0.8×	16 0.4×	55 1.5×	12	341

Countries citing papers authored by Naoto Ishibashi

Since Specialization

Citations

This map shows the geographic impact of Naoto Ishibashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoto Ishibashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoto Ishibashi more than expected).

Fields of papers citing papers by Naoto Ishibashi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoto Ishibashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoto Ishibashi. The network helps show where Naoto Ishibashi may publish in the future.

Co-authorship network of co-authors of Naoto Ishibashi

This figure shows the co-authorship network connecting the top 25 collaborators of Naoto Ishibashi. A scholar is included among the top collaborators of Naoto Ishibashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoto Ishibashi. Naoto Ishibashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Sato, Noriko, Naoto Ishibashi, Kanako Miyano, et al.. (2019). A New Lead Identification Strategy: Screening an sp³‐rich and Lead‐like Compound Library Composed of 7‐Azanorbornane Derivatives. ChemMedChem. 14(21). 1840–1848. 6 indexed citations

Miyano, Kanako, Shigeto Hirayama, Yuki Yoshida, et al.. (2018). Neuropeptide oxytocin enhances μ opioid receptor signaling as a positive allosteric modulator. Journal of Pharmacological Sciences. 137(1). 67–75. 55 indexed citations

Qin, Xian‐Yang, Hideki Tatsukawa, Kiyotaka Hitomi, et al.. (2016). Metabolome Analyses Uncovered a Novel Inhibitory Effect of Acyclic Retinoid on Aberrant Lipogenesis in a Mouse Diethylnitrosamine-Induced Hepatic Tumorigenesis Model. Cancer Prevention Research. 9(3). 205–214. 12 indexed citations

Tatsukawa, Hideki, Naoto Ishibashi, Tomokazu Matsuura, et al.. (2015). Molecular mechanism by which acyclic retinoid induces nuclear localization of transglutaminase 2 in human hepatocellular carcinoma cells. Cell Death and Disease. 6(12). e2002–e2002. 26 indexed citations

Zheng, Yun‐Wen, T. Tsuchida, Bin Li, et al.. (2014). The CD133 ⁺ CD44 ⁺ Precancerous Subpopulation of Oval Cells Is a Therapeutic Target for Hepatocellular Carcinoma. Stem Cells and Development. 23(18). 2237–2249. 23 indexed citations

Qin, Xian‐Yang, Feifei Wei, Masaru Tanokura, et al.. (2013). The Effect of Acyclic Retinoid on the Metabolomic Profiles of Hepatocytes and Hepatocellular Carcinoma Cells. PLoS ONE. 8(12). e82860–e82860. 18 indexed citations

Tatsukawa, Hideki, Tetsuro Sano, Naoto Ishibashi, et al.. (2011). Dual induction of caspase 3- and transglutaminase-dependent apoptosis by acyclic retinoid in hepatocellular carcinoma cells. Molecular Cancer. 10(1). 4–4. 35 indexed citations

Kimura, Mitsutoshi, et al.. (2010). Acyclic retinoid NIK-333 accelerates liver regeneration and lowers serum transaminase activities in 70% partially hepatectomized rats, in vivo. European Journal of Pharmacology. 643(2-3). 267–273. 13 indexed citations

Komi, Yusuke, Naoto Ishibashi, Yasufumi Sato, et al.. (2009). Acyclic retinoid inhibits angiogenesis by suppressing the MAPK pathway. Laboratory Investigation. 90(1). 52–60. 27 indexed citations

10.

Tsuchiya, Hiroyuki, Yuji Akechi, Tomohiko Sakabe, et al.. (2008). Suppressive Effects of Retinoids on Iron-Induced Oxidative Stress in the Liver. Gastroenterology. 136(1). 341–350.e8. 51 indexed citations

11.

Sakabe, Tomohiko, Hiroyuki Tsuchiya, Michiko Endo, et al.. (2007). An antioxidant effect by acyclic retinoid suppresses liver tumor in mice. Biochemical Pharmacology. 73(9). 1405–1411. 12 indexed citations

12.

Suzuki, Toru, Kenichi Aizawa, Takayoshi Matsumura, et al.. (2007). Acyclic Retinoid Inhibits Neointima Formation Through Retinoic Acid Receptor Beta-Induced Apoptosis. Arteriosclerosis Thrombosis and Vascular Biology. 27(7). 1535–1541. 8 indexed citations

13.

Sano, Tetsuro, Masataka Kagawa, Masataka Okuno, et al.. (2005). Prevention of Rat Hepatocarcinogenesis by Acyclic Retinoid Is Accompanied by Reduction in Emergence of Both TGF-α-Expressing Oval-Like Cells and Activated Hepatic Stellate Cells. Nutrition and Cancer. 51(2). 197–206. 29 indexed citations

14.

Anzai, Yuichiro, et al.. (1979). Knowledge-based problem solving by a labelled production system. 22–24. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact